-
EU approves AstraZeneca’s drug for adjunct use in Type-1 diabetes
(Reuters) – British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease. Forxiga can now be used along with insulin in patients with Type-1 diabetes and a Body…
-
First European study tests pioneering stem cell therapy in people with type 1 diabetes
A group of people with type 1 diabetes have become the first in Europe to receive a pioneering stem cells treatment that could restore blood glucose control. PEC-Direct islet cell replacement therapy (also known as VC-02) has been designed to replace insulin-producing beta cells in people with type 1 diabetes.…
